Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Neoplasia”

10,506 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,506 results

Testing effectiveness (Phase 2)UnknownNCT03188159
What this trial is testing

Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube Cancer
National University Hospital, Singapore 36
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Not applicableNot Yet RecruitingNCT06647602
What this trial is testing

Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy

Who this might be right for
Differentiated Thyroid CancerThyroid CancerLevothyroxine+2 more
University Medical Center Groningen 40
Testing effectiveness (Phase 2)Looking for participantsNCT06540937
What this trial is testing

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

Who this might be right for
Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Not applicableStudy completedNCT00383279
What this trial is testing

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

Who this might be right for
Cervical CancerOvarian CancerSarcoma
Wake Forest University Health Sciences 70
Testing effectiveness (Phase 2)Study completedNCT00036842
What this trial is testing

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Who this might be right for
Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
SWOG Cancer Research Network
Not applicableStudy completedNCT03204461
What this trial is testing

Glucose Metabolism in Different PCOS Phenotypes

Who this might be right for
Polycystic Ovary SyndromeGlucose IntoleranceLiver Fat+1 more
Medical University of Vienna 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Large-scale testing (Phase 3)Study completedNCT01196741
What this trial is testing

Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
University College, London 107
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Early research (Phase 1)Study completedNCT00405405
What this trial is testing

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerParotid Gland CancerThyroid Gland Cancer+2 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 13
Large-scale testing (Phase 3)Study completedNCT00997594
What this trial is testing

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Who this might be right for
Adrenal Tumors
Mie University 18
Testing effectiveness (Phase 2)Study completedNCT01303029
What this trial is testing

Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06479239
What this trial is testing

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic Cancer
University of Virginia 23
Not applicableLooking for participantsNCT05950282
What this trial is testing

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Who this might be right for
Insulin ResistancePolycystic Ovary SyndromeHyperinsulinism+2 more
Lilli Health 500
Large-scale testing (Phase 3)Temporarily pausedNCT00865488
What this trial is testing

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

Who this might be right for
Ovarian CystsEndometriosisAdhesions
OMRIX Biopharmaceuticals 80
Large-scale testing (Phase 3)Ended earlyNCT04592861
What this trial is testing

Carbon Ion RT for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Einstein College of Medicine 5
Testing effectiveness (Phase 2)Ended earlyNCT01133756
What this trial is testing

E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125

Who this might be right for
Ovarian Cancer
Eisai Inc. 7
Not applicableStudy completedNCT02057029
What this trial is testing

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Who this might be right for
Breast CancerEarly Stage Estrogen Receptor (ER) Positive Breast Cancer
Yale University 96
Load More Results